Table 3.

End-organ activity in subjects^* with follicles ≥18mm in either Cycle 2 and/or Cycle 4. Maximum value for each parameter during the Cycle.

Study Group	Cycle 2 (Baseline)						Cycle 4 (after randomization)
	Follicle size (mm)	E2 >75pg/mL	P ng/mL	LH mIU/mL	FSH mIU/mL	Cervical mucus score	Follicle size (mm)	E2 >75pg/mL	P ng/mL	LH mIU/mL	FSH mIU/mL	Cervical mucus score
Cyclic	27	192	0.22	8.39	8.19	5	7.60	28	0.19	6.77	6.47	5
Cyclic	50.9	619	2.23	10.62	5.80	6	13	55	0.63	8.08	8.87	3
Cyclic	9.14	58	0.77	12.07	7.85	6	25.54	160	0.80	4.97	6.06	9
Cyclic	18.1	87	0.38	8.95	15.35	4	8.50	70	0.35	7.14	5.87	4
Cyclic	31.6	679	0.83	13.54	5.18	5	9	55	0.50	7.30	5.51	4
Cyclic	18.25	105	0.47	11.41	8.24	3	10.40	53	0.55	5.28	5.63	4
Continuous	31.4	452	1.10	10.42	7.47	5	8	41	1.11	13.05	7.91	5
Continuous	26.2	481	0.29	5.95	8.63	2	15.80	78	0.39	9.34	8.38	6
Continuous	36.3	855	0.22	10.92	10.70	3	9.32	27	0.18	8.59	8.24	3
Continuous	37	581	0.74	8.09	4.15	5	12.00	29	0.59	5.53	5.02	5
Continuous	23.88	283	0.69	8.54	7.56	4	6.30	16	0.60	3.78	5.95	1
Continuous	36.4	750	0.58	7.64	10.40	6	31.90	615	0.54	14.33	9.22	4
Continuous	28.2	125	5.17	4.94	7.67	4	6.04	47	0.42	2.61	4.27	3
Continuous	20.34	145	0.37	10.48	9.95	5	21.84	44	0.40	9.02	12.24	3

^*each line represents a single subject’s values